Manuela Sarti

Here below are the publications (3) participated by Manuela Sarti along with Erica Montani (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations).

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) Interaction of CDCP1 with HER2 enhances HER2-driven tumorigenesis and promotes trastuzumab resistance in breast cancer

Cell Reports, 28 aprile 2015

2) Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity

Cell Reports, 9 ottobre 2014

3) Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer

Nature, 6 novembre 2014

Facts & figures

Manuela Sarti has coordinated or participated in 3 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 6 elements tag cloud:

breast cancer (1) cancer (1) chemotherapy (1) HER2 (1) myeloid cells (1) prostate tumors (1)

Manuela Sarti has coordinated or participated in 3 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 2 scientific journals:

Cell Reports (2) Nature (1)

Manuela Sarti has coordinated or participated in 3 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 22 co-authors being active in Ticino:

Sandra Pinton (3) Carlo Catapano (3) Andrea Alimonti (3) Ramon Garcia-Escudero (3) Ilaria Guccini (3) Erica Montani (3) Diletta Di Mitri (2) Fabio Grassi (2) Alberto Toso (2) Abdullah Alajati (1) Camilla Marini (1) Ajinkya Revandkar (1) Tanja Rezzonico Jost (1) Francesco Bertoni (1) Jing Jing Chen (1) Madhuri Kalathur (1) David Jarrossay (1) Tiziano Bernasocchi (1) Rocco D’Antuono (1) Michele Proietti (1) Andrea Rinaldi (1) Gianluca Civenni (1)

Manuela Sarti has coordinated or participated in 3 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 19 most frequently used terms (excluding 14 not relevant terms) are here listed:

M.S. WORD CLOUD cancer (2) cdcp (1) enhances (1) driven (1) tumorigenesis (1) trastuzumab (1) breast (1) chemotherapy (1) pten-deficient (1) prostate (1) tumors (1) activating (1) senescence-associated (1) antitumor (1) tumour-infiltrating (1) gr (1) myeloid (1) antagonize (1) senescence (1)

In the synopsis of the whole 3138 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 173 most frequently used terms (excluding 14 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (281) covid- (182) thyroid (108) sars-cov- (102) prostate (101) pet (101) cardiac (97) hiv (83) atrial (75) coronary (75) breast (74) pandemic (67) sclerosis (67) lymphoma (66) fibrillation (65) bone (53) aortic (51) artery (49) heart (48) liver (46) stroke (46) brain (43) carcinoma (43) antibodies (41) lung (38) mri (38) cardiovascular (36) transcatheter (35) ventricular (35) nodules (34) dna (34) virus (33) extracellular (32) metastatic (32) myocardial (31) tumor (30) kidney (29) oncology (29) ultrasound (28) knee (27) esmo (26) f-fdg (26) antibody (26) vesicles (25) spinal (25) mitral (25) hepatitis (24) ischemic (23) cervical (23) infarction (22) tuberculosis (22) ehra (22) antiplatelet (22) diabetes (22) sperm (22) pulmonary (21) radiotherapy (21) chemotherapy (21) renal (21) ovarian (21) percutaneous (21) osteoarthritis (20) implantation (20) vaccination (20) sentinel (20) transplantation (19) blood (19) nuclear (18) urinary (18) tomography (18) pacing (18) tumors (18) bacterial (18) b-cell (17) resonance (17) endovascular (17) monoclonal (17) bladder (17) lymph (17) laparoscopic (17) colorectal (17) mice (17) coronavirus (16) immunodeficiency (16) transplant (15) musculoskeletal (15) vascular (15) fdg (15) implantable (15) lymphomas (14) plasma (14) vaccine (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) autoimmune (13) mrna (13) biomarker (13) nerve (13) pneumonia (13) biomarkers (13) radiomics (13) metabolic (13) tricuspid (13) preclinical (13) metabolism (13) serum (13) metastasis (13) pregnancy (13) lymphocytic (13) conference (12) malignancy (12) membrane (12) grafts (12) ischemia (12) endometrial (12) fna (12) joint (12) brugada (12) antiretroviral (12) legs (12) male (12) arterial (12) dementia (12) esc (12) hemorrhage (12) behavior (12) pi (11) burden (11) cytology (11) signaling (11) pathways (11) contemporary (11) adherence (11) catheter (11) contrast-enhanced (11) limb (11) tau (11) parkinson (11) radiation (11) senescence (11) neck (11) hiv- (11) mesenchymal (11) lockdown (11) mutations (11) medullary (11) il- (11) infectious (10) cancers (10) igg (10) intravenous (10) arrhythmia (10) vitamin (10) interventions (10) prophylaxis (10) migraine (10) follicular (10) gastric (10) prognosis (10) metastases (10) skin (10) incontinence (10) muscle (10) anesthesia (10) epidemiology (10) lipid (10) baseline (10) refractory (10) malignant (10) occlusion (10) dynamic (10)

Scientific researchers in Ticino

Manuela Sarti has participated - as a whole - in 3 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Erica Montani

1) Interaction of CDCP1 with HER2 enhances HER2-driven tumorigenesis and promotes trastuzumab resistance in breast cancer

2) Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity

3) Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer

Manuela Sarti has participated - as a whole - in 3 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) - here below are the ones participated along with Erica Montani